Indaptus Therapeutics closes $24 million private placement
INDP•Indaptus Therapeutics completed a private placement on October 16, 2026, raising approximately $24 million in gross proceeds before expenses and issuing 20,338,974 shares of common stock.
1. Placement completed
Indaptus Therapeutics completed its private placement on October 16, 2026, after receiving the full purchase price from all purchasers. The company will issue 20,338,974 shares of common stock and raised approximately $24 million in gross proceeds before offering expenses.
